In MedTech Dive, Nemphos Braue highlights 5 reasons why healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase.
M&A
Press Release: SealingTech Acquisition
Nemphos Braue worked closely with the leadership team at SealingTech through this and previous negotiations to positively impact the company’s strong growth trajectory and position it for a successful exit.
Nemphos Braue Once Again Named Best Law Firm for Intellectual Property and M&A
The Daily Record’s Reader Rankings for 2023 are in – and Nemphos Braue is a winner for Best Law Firm!
George Nemphos Speaks to Students at Morgan State University
As part of the “Wall Street Comes to Baltimore” event, Nemphos participated in the M&A panel.
What to do BEFORE the Acquisition
Providing insights and perspective from the deal-making frontlines, Bill Lenihan, Industry Leader at Hartman Executive Advisors, and George Nemphos, Co-Founder and Managing Member of Nemphos Braue, offered up details on what they’re seeing in the red-hot acquisition marketplace.
M&A: The “COVID Hangover” and Fielding the Best Team
George Nemphos shares details on what he sees as the “COVID hangover” and tips on fielding the best team on the field when going into a deal.
Latest Insights
View All
CTA Update: New Deadline Now in Effect
BOI reporting requirements under the CTA are back in effect. The new deadline for most reporting companies is now March 21, 2025.
Trade Secrets and MedTech: IP in the News
The decision in a lawsuit involving Insulet’s Omnipod insulin pumps provides a vivid reminder on the value of trade secrets and the need to protect them.
MedTech M&A is Poised for Growth
In MedTech Dive, Nemphos Braue highlights 5 reasons why healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase.
